Allogeneic Faecal Microbiota, Pooled — Drug Intelligence | 20 EU Trials

Filter these 20 trials by condition, phase, country and more.

Open in Search →

20 Registered trials

9 Recruiting

4 Completed trials

7 Sponsors

8 Countries

Phase III

Phase II/III

Phase II

Phase III: 6 Phase II/III: 2 Phase II: 11 Phase III/IV: 1

Oversight events:

2 serious breaches 1 temporary halt 1 urgent safety measure 1 unexpected event across 3 trials

View oversight register →

Indications tested

Non-alcoholic steatohepatitis 2 Non-small cell lung cancer 1 Acute graft versus host disease in intestine 1 Crohn's disease 1 Axial spondyloarthritis 1 Autism spectrum disorder 1 Irritable bowel syndrome 1 Type 2 diabetes mellitus 1 Allogenic stem cell transplantation 1 Gastrointestinal disorder 1

Sponsors using this IMP

Assistance Publique Hopitaux De Paris 10 Maat Pharma 3 Mikrobiomik Healthcare Company S.L. 3 Consorcio Centro De Investigacion Biomedica En Red 1 Fakultni Nemocnice Kralovske Vinohrady 1 Friedrich-Schiller-Universitaet Jena 1 Institut Gustave Roussy 1

All trials

20 total

Study of the faecal microbiota transfer in capsule form vs. placebo for the treatment of patients with non-alcoholic steatohepatitis Pending

2022-500185-94-01 Phase II 1 country Mikrobiomik Healthcare Company S.L.
Fecal microbiota transplantation for primary sclerosing cholangitis - randomized study versus sham transplantation (FMT-SCLER). Pending

2023-505469-95-00 Phase II/III 1 country Assistance Publique Hopitaux De Paris
Oral Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis (UC) Pending

2024-518044-20-00 Phase II 1 country Assistance Publique Hopitaux De Paris
Transmission of bacteria from healthy donor stool to the patients gut as first-line treatment of postantibiotic diarrhoea in the critically … Pending

2024-519024-25-00 Phase II 1 country Fakultni Nemocnice Kralovske Vinohrady
FELICITA - A proof of concept study: open label phase IIa trial evaluating the effect and safety of transplantation of fecal microbiota in c… Pending

2025-520539-17-00 Phase II 1 country Assistance Publique Hopitaux De Paris
A medical research to evaluate if MaaT013 is safe and helps children and adolescent with GI-aGvHD after failed two prior therapies. Pending

2025-524302-15-00 Phase II 4 countries MaaT PHARMA
Fecal transplantation to Eradicate Colonizing Emergent Superbugs Recruiting

2024-516393-29-00 Phase III 1 country Assistance Publique Hopitaux De Paris
A randomized multicenter Phase II trial evaluating oral pooled fecal microbiotherapy (MaaT033) concomitant to Cemiplimab (CB) versus best in… Recruiting

2024-517018-14-00 Phase II 1 country Institut Gustave Roussy
ICEBOAT. A prospective, multi-center, double blind randomized trial of fecal microbiota transplantation (FMT) delivered by capsule versus pl… Recruiting

2024-516099-13-00 Phase III 1 country Assistance Publique Hopitaux De Paris
Fecal Microbiome Transplantation in Cirrhosis. Randomized, Double-blinded, Placebo-Controlled trial in patients with decompensated cirrhosis… Recruiting

2023-509151-13-00 Phase III 1 country Consorcio Centro De Investigacion Biomedica En Red
Fecal Microbiota Transplantation Trial in Axial Spondyloarthritis Recruiting

2023-504852-89-00 Phase II 1 country Assistance Publique Hopitaux De Paris
Clinical trial with MBK-01, intestinal microbiota capsules, for the treatment of patients with recurring diverticulitis Recruiting

2023-506224-87-00 Phase II 1 country Mikrobiomik Healthcare Company S.L.
Fecal microbiota transfer to improve diabetes control post-bariatric surgery Recruiting

2024-511870-65-00 Phase III 1 country Assistance Publique Hopitaux De Paris
A multi-center randomized, double blinded phase IIb trial evaluating oral pooled fecal microbiotherapy MaaT033 to prevent allogeneic hematop… Recruiting

2022-501831-18-00 Phase II 5 countries Maat Pharma
Fecal microbiota transplantation in Crohn’s disease as relay after anti-TNF withdrawal (MIRACLE) Recruiting

2024-511822-30-00 Phase III/IV 1 country Assistance Publique Hopitaux De Paris
REBALANCE UC : impact of Fecal Microbiota Transplantation in ulcerative colitis:a randomized, sham controlled trial Ended

2024-511863-27-01 Phase II/III 1 country Assistance Publique Hopitaux De Paris
Multicenter, prospective, double-blind, randomized, three-armed, placebo-controlled study of long-term therapeutic transfer of encapsulated … Ended

2024-517132-22-00 Phase III 1 country Friedrich-Schiller-Universitaet Jena
PICASSO. Prospective randomIzed clinical trial assessing the tolerance and clinical benefit of feCAl tranSplantation in patientS with melanO… Ended

2024-516100-42-00 Phase II 1 country Assistance Publique Hopitaux De Paris
EvAluation of the efficacy of MaaT013 as salvage theRapy in acute GVHD patiEntS with gastrointestinal involvement, refractory to ruxolitinib… Ended

2024-513023-17-00 Phase III 6 countries MaaT PHARMA
Study of the faecal microbiota transfer in capsule form vs. placebo for the treatment of patients with non-alcoholic steatohepatitis Expired

2022-500185-94-00 Phase II 1 country Mikrobiomik Healthcare Company S.L.

Showing 1–20 of 20 trials

← All drugs A–Z